(Q39440683)

12 September 2017

Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial (English)

1 reference

12 September 2017

phase III clinical trial

0 references

0 references

0 references

0 references

5

1 reference

12 September 2017

11

Gerd Fätkenheuer

1 reference

12 September 2017

12

Uwe Wollina

1 reference

12 September 2017

33

Bernd Jilma

1 reference

12 September 2017

1

Michael Schwameis

1 reference

12 September 2017

Thomas Kündig

2

1 reference

12 September 2017

Gustave Huber

3

1 reference

12 September 2017

Luzi von Bidder

4

1 reference

12 September 2017

Roland Weisser

6

1 reference

12 September 2017

Elisabeth Aberer

7

1 reference

12 September 2017

Georg Härter

8

1 reference

12 September 2017

Thomas Weinke

9

1 reference

12 September 2017

Tomas Jelinek

10

1 reference

12 September 2017

Gerd-Dieter Burchard

13

1 reference

12 September 2017

Roland Aschoff

14

1 reference

12 September 2017

Ruth Nischik

15

1 reference

12 September 2017

Gerhard Sattler

16

1 reference

12 September 2017

Georg Popp

17

1 reference

12 September 2017

Wolfgang Lotte

18

1 reference

12 September 2017

Dirk Wiechert

19

1 reference

12 September 2017

Gerald Eder

20

1 reference

12 September 2017

Olga Maus

21

1 reference

12 September 2017

Petra Staubach-Renz

22

1 reference

12 September 2017

Andrea Gräfe

23

1 reference

12 September 2017

Veronika Geigenberger

24

1 reference

12 September 2017

Ingomar Naudts

25

1 reference

12 September 2017

Michael Sebastian

26

1 reference

12 September 2017

Norbert Reider

27

1 reference

12 September 2017

Ridwan Weber

28

1 reference

12 September 2017

Marc Heckmann

29

1 reference

12 September 2017

Emil C Reisinger

30

1 reference

12 September 2017

Georg Klein

31

1 reference

12 September 2017

Johannes Wantzen

32

1 reference

12 September 2017

19 December 2016

1 reference

Lancet Infectious Diseases

12 September 2017

1 reference

12 September 2017

17

1 reference

12 September 2017

3

1 reference

12 September 2017

322-329

1 reference

Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

What should one do in case of a tick bite?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Lyme borreliosis: clinical case definitions for diagnosis and management in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Does this patient have erythema migrans?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Delayed dissemination of Lyme disease spirochetes from the site of deposition in the skin of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Evaluation of the preventive capacities of a topically applied azithromycin formulation against Lyme borreliosis in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Efficacy of an experimental azithromycin cream for prophylaxis of tick-transmitted lyme disease spirochete infection in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

The pharmacokinetics of azithromycin and their clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008-2011.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Prevalence of Borrelia burgdorferi sensu lato genospecies in Ixodes ricinus ticks in Europe: a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

The prevalence of Borrelia miyamotoi infection, and co-infections with other Borrelia spp. in Ixodes scapularis ticks collected in Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Prevalence of Borrelia burgdorferi and Anaplasma phagocytophilum in Ixodes scapularis (Acari: Ixodidae) nymphs collected in managed red pine forests in Wisconsin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Comparison of erythema migrans caused by Borrelia afzelii and Borrelia garinii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

Prospective study of serologic tests for lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930529-1

7 January 2021

10.1016/S1473-3099(16)30529-1

Identifiers

DOI

1 reference

release_y65onrpqhrfehlcyxdnxpefx7u

12 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y65onrpqhrfehlcyxdnxpefx7u

24 November 2022

mapped directly with Wikidata item

1 reference